Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Hypertension. 2010 Nov 15;57(1):94–102. doi: 10.1161/HYPERTENSIONAHA.110.160242

Figure 2. Pro-angiogenic PGF is downregulated, whereas anti-angiogenic sFLT1 is unchanged or even decreased in BPH/5.

Figure 2

A) Summary of free plasma PGF levels as determined by ELISA in non-pregnant (NP) and at different gestational stages of C57 and BPH/5 (n=4-6 per group). B) Summary of Pgf mRNA expression from placental tissue at different gestational days (n=5 per group). Data are expressed relative to C57 at e9.5. C) Summary of circulating sFLT1 levels as determined by ELISA in NP and at different gestational stages of C57 and BPH/5 (n=4-6 per group). D) Summary of real-time qPCR analysis of sFlt1 from placental tissue of C57 and BPH/5 at different gestational days (n=5 per group). *p<0.05 vs NP in matched strain; †p<0.05 vs. time-matched C57.